Evidence map›Paper›PMID 33919815›Full record

ArticleCancers2021

Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria.

Madlen Reschke, Eva Biewald, Leo Bronstein, Ines B Brecht, Sabine Dittner-Moormann, Frank Driever, Martin Ebinger, Gudrun Fleischhack, Desiree Grabow, Dirk Geismar and 27 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Special Issue ofCancers · 2023
    Article
  9. Article
  10. Bilateral medulloepithelioma of the ciliary body: a case report.International journal of ophthalmology · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 10 institutions in 2 countries.

Madlen ReschkeDepartment of Pediatric Hematology and Oncology, Charité-Universitätsmedizin, 13353 Berlin, Germany.
Eva BiewaldDepartment of Ophthalmology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Leo BronsteinInstitute of Biostatistics and Clinical Research, University of Muenster, 48149 Münster, Germany.
Ines B BrechtDepartment of Pediatric Hematology and Oncology, Children's University Hospital Tübingen, 72076 Tübingen, Germany.
Sabine Dittner-MoormannDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Frank DrieverInstitute of Pathology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
Martin EbingerDepartment of Pediatric Hematology and Oncology, Children's University Hospital Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-4229-8058
Gudrun FleischhackDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.ORCID 0000-0001-5714-007X
Desiree GrabowDivision of Childhood Cancer Epidemiology, German Childhood Cancer Registry at Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Dirk GeismarClinic for Particle Therapy, West German Proton Therapy Centre Essen (WPE), University Hospital Essen, 45122 Essen, Germany.
Sophia GörickeDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45122 Essen, Germany.
Maja GuberinaDepartment for Radiotherapy, University Hospital Essen, 45122 Essen, Germany.
Claudia H D Le GuinDepartment of Ophthalmology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.ORCID 0000-0002-6088-6929
Tobias KieferDepartment of Ophthalmology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Christian P KratzDepartment of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0003-4120-5873
Klaus MetzInstitute of Pathology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.
Bert MüllerDepartment of Ophthalmology, Charité-Universitätsmedizin, 13353 Berlin, Germany.
Tatsiana RylDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Marc SchlamannDepartment of Neuroradiology, University Hospital Köln, 50937 Köln, Germany.
Sabrina SchlüterDepartment of Ophthalmology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Stefan SchönbergerDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.ORCID 0000-0002-7222-296X
Johannes H SchulteDepartment of Pediatric Hematology and Oncology, Charité-Universitätsmedizin, 13353 Berlin, Germany.
Selma SirinDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45122 Essen, Germany.ORCID 0000-0003-4555-0367
Daniela SüsskindDepartment of Ophthalmology, University Hospital Tübingen, 72076 Tübingen, Germany.
Beate TimmermannClinic for Particle Therapy, West German Proton Therapy Centre Essen (WPE), University Hospital Essen, 45122 Essen, Germany.
Saskia TingInstitute of Pathology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.ORCID 0000-0003-1415-7714
Werner WackernagelDepartment of Ophthalmology, Medical University of Graz, 8036 Graz, Austria.
Regina WielandDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Martin ZenkerInstitute of Human Genetics, University Magdeburg, 39120 Magdeburg, Germany.
Michael ZeschnigkInstitute of Human Genetics, Medical Faculty, University Duisburg-Essen, 45122 Essen, Germany.
Dirk ReinhardtDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.ORCID 0000-0002-7027-4483
Angelika EggertDepartment of Pediatric Hematology and Oncology, Charité-Universitätsmedizin, 13353 Berlin, Germany.
Petra Ritter-SovinzDivision of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, 8036 Graz, Austria.
Dietmar R LohmannGerman Consortium for Translational Cancer Research (DKTK), Standort Essen/Düsseldorf, 45122 Essen, Germany.ORCID 0000-0002-2624-9889
Norbert BornfeldDepartment of Ophthalmology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Nikolaos BechrakisDepartment of Ophthalmology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.
Petra KettelerDepartment of Pediatric Hematology and Oncology, University Hospital Essen, University Duisburg Essen, 45122 Essen, Germany.ORCID 0000-0002-8138-0441
University of Duisburg-Essen · DECharité - Universitätsmedizin Berlin · DEEssen University Hospital · DEUniversity Children's Hospital Tübingen · DEMedical University of Graz · ATJohannes Gutenberg University Mainz · DEMedizinische Hochschule Hannover · DEUniversity Hospital Cologne · DEUniversity Hospital Magdeburg · DEUniversity of Münster · DE

Funding

Deutsche Kinderkrebsstiftung 2013.11Deutsche Kinderkrebsstiftung 2016.09Deutsche Kinderkrebsstiftung 2018.12
6 · The paper itself

Abstract

Retinoblastoma and other eye tumors in childhood are rare diseases. Many eye tumors are the first signs of a genetic tumor predisposition syndrome and the affected children carry a higher risk of developing other cancers later in life. Clinical and genetic data of all children with eye tumors diagnosed between 2013-2018 in Germany and Austria were collected in a multicenter prospective observational study. In five years, 300 children were recruited into the study: 287 with retinoblastoma, 7 uveal melanoma, 3 ciliary body medulloepithelioma, 2 retinal astrocytoma, 1 meningioma of the optic nerve extending into the eye. Heritable retinoblastoma was diagnosed in 44% of children with retinoblastoma. One child with meningioma of the optic nerve extending into the eye was diagnosed with neurofibromatosis 2. No pathogenic constitutional variant in

Indexed as

cancer predisposition syndromeciliary body medulloepitheliomaDICER1 syndromegenetic counselingnevus Otaretinal astrocytomaretinoblastomauveal melanoma

Identifiers

PMID33919815
PMCPMC8070790
OpenAlexW3153649348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.